Myriad Genetics (MYGN) EPS (Diluted) Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -26.00% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 10.17% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -9.29% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 10.86% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 21.11% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.61% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -18.66% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 257.85% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -0.54% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 18.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.52% |
| Dec 31, 2025 | 45.42% |
| Sep 30, 2025 | 12.21% |
| Jun 30, 2025 | -173.12% |
| Mar 31, 2025 | 83.77% |
| Dec 31, 2024 | -68.85% |
| Sep 30, 2024 | -41.04% |
| Jun 30, 2024 | -88.08% |
| Mar 31, 2024 | 17.75% |
| Dec 31, 2023 | 19.03% |
| Sep 30, 2023 | -54.37% |
| Jun 30, 2023 | -24.08% |
| Mar 31, 2023 | 24.22% |
| Dec 31, 2022 | -67.33% |
| Sep 30, 2022 | -15.88% |
| Jun 30, 2022 | -45.80% |
| Mar 31, 2022 | -68.43% |
| Dec 31, 2021 | -69.47% |
| Sep 30, 2021 | 209.14% |
| Jun 30, 2021 | -32.04% |